Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionMichael J. Peluso, Timothy J. Henrich, Matthew S. Durstenfeld et al.|The Journal of Infectious Diseases|2021Cited by 332
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Owen Janson et al.|Cell Reports|2021Cited by 266
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Monica Gandhi et al.|Science Advances|2021Cited by 150